Gallmeier E - Search Results

1

Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.

Cunningham SC, Gallmeier E, Hucl T, Dezentje DA, Calhoun ES, Falco G, Abdelmohsen K, Gorospe M, Kern SE. Cunningham SC, et al. Among authors: gallmeier e. Cancer Res. 2006 Jun 1;66(11):5560-4. doi: 10.1158/0008-5472.CAN-06-0555. Cancer Res. 2006. PMID: 16740690

2

Absence of specific cell killing of the BRCA2-deficient human cancer cell line CAPAN1 by poly(ADP-ribose) polymerase inhibition.

Gallmeier E, Kern SE. Gallmeier E, et al. Cancer Biol Ther. 2005 Jul;4(7):703-6. doi: 10.4161/cbt.4.7.1909. Epub 2005 Jul 10. Cancer Biol Ther. 2005. PMID: 16082177 Free article.

3

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor.

van der Heijden MS, Brody JR, Dezentje DA, Gallmeier E, Cunningham SC, Swartz MJ, DeMarzo AM, Offerhaus GJ, Isacoff WH, Hruban RH, Kern SE. van der Heijden MS, et al. Among authors: gallmeier e. Clin Cancer Res. 2005 Oct 15;11(20):7508-15. doi: 10.1158/1078-0432.CCR-05-1048. Clin Cancer Res. 2005. PMID: 16243825

4

Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.

Cunningham SC, Gallmeier E, Hucl T, Dezentje DA, Abdelmohsen K, Gorospe M, Kern SE. Cunningham SC, et al. Among authors: gallmeier e. Cell Cycle. 2006 May;5(10):1090-3. doi: 10.4161/cc.5.10.2805. Epub 2006 May 15. Cell Cycle. 2006. PMID: 16721048

5

Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.

Calhoun ES, Hucl T, Gallmeier E, West KM, Arking DE, Maitra A, Iacobuzio-Donahue CA, Chakravarti A, Hruban RH, Kern SE. Calhoun ES, et al. Among authors: gallmeier e. Cancer Res. 2006 Aug 15;66(16):7920-8. doi: 10.1158/0008-5472.CAN-06-0721. Cancer Res. 2006. PMID: 16912165

6

Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.

Brody JR, Hucl T, Gallmeier E, Winter JM, Kern SE, Murphy KM. Brody JR, et al. Among authors: gallmeier e. Cancer Res. 2006 Oct 1;66(19):9369-73. doi: 10.1158/0008-5472.CAN-06-2165. Cancer Res. 2006. PMID: 17018589

7

Targeting Fanconi anemia/BRCA2 pathway defects in cancer: the significance of preclinical pharmacogenomic models.

Gallmeier E, Kern SE. Gallmeier E, et al. Clin Cancer Res. 2007 Jan 1;13(1):4-10. doi: 10.1158/1078-0432.CCR-06-1637. Clin Cancer Res. 2007. PMID: 17200332 Review.

8

High-throughput screening identifies novel agents eliciting hypersensitivity in Fanconi pathway-deficient cancer cells.

Gallmeier E, Hucl T, Brody JR, Dezentje DA, Tahir K, Kasparkova J, Brabec V, Bachman KE, Kern SE. Gallmeier E, et al. Cancer Res. 2007 Mar 1;67(5):2169-77. doi: 10.1158/0008-5472.CAN-06-2711. Cancer Res. 2007. PMID: 17332347

9

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.

Gallmeier E, Hucl T, Calhoun ES, Cunningham SC, Bunz F, Brody JR, Kern SE. Gallmeier E, et al. Cancer Biol Ther. 2007 May;6(5):654-60. doi: 10.4161/cbt.6.5.3978. Epub 2007 Feb 7. Cancer Biol Ther. 2007. PMID: 17387268 Free article.

10

High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.

Hucl T, Brody JR, Gallmeier E, Iacobuzio-Donahue CA, Farrance IK, Kern SE. Hucl T, et al. Among authors: gallmeier e. Cancer Res. 2007 Oct 1;67(19):9055-65. doi: 10.1158/0008-5472.CAN-07-0474. Cancer Res. 2007. PMID: 17909009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters